MECLIZINE HYDROCHLORIDE - meclizine hydrochloride tablet 
Epic Pharma, LLC

----------

DESCRIPTION

Chemically, meclizine hydrochloride is 1-(p-chloro-α-phenylbenzyl)-4-(m-methylbenzyl) piperazine dihydrochloride monohydrate.

Chemical Structure

C25H27CIN2·2HCl·H20 M.W. 481.89

Meclizine hydrochloride tablets, USP are available in two different strengths, 12.5 mg and 25 mg. Inactive ingredients: microcrystalline cellulose, lactose monohydrate, croscarmellose sodium and magnesium stearate. The 12.5 mg tablet also contains FD&C Blue #1 Aluminum Lake.

CLINICAL PHARMACOLOGY

Meclizine hydrochloride is an antihistamine which shows marked protective activity against nebulized histamine and lethal doses of intravenously injected histamine in guinea pigs. It has a marked effect in blocking the vasodepressor response to histamine, but only a slight blocking action against acetylcholine. Its activity is relatively weak in inhibiting the spasmogenic action of histamine on isolated guinea pig ileum.

INDICATIONS AND USAGE

For the management of nausea and vomiting, and dizziness associated with motion sickness.

CONTRAINDICATIONS

Meclizine hydrochloride is contraindicated in individuals who have shown a previous hypersensitivity to it.

WARNINGS

Since drowsiness may, on occasion, occur with use of this drug, patients should be warned of this possibility and cautioned against driving a car or operating dangerous machinery.

Patients should avoid alcoholic beverages while taking this drug.

Due to its potential anticholinergic action, this drug should be used with caution in patients with asthma, glaucoma, or enlargement of the prostate gland.

PRECAUTIONS

Pediatric Use

Clinical studies establishing safety and effectiveness in children have not been done; therefore, usage is not recommended in children under 12 years of age.

Pregnancy Use

Pregnancy Category B

Reproduction studies in rats have shown cleft palates at 25-50 times the human dose. Epidemiological studies in pregnant women, however, do not indicate that meclizine increases the risk of abnormalities when administered during pregnancy. Despite the animal findings, it would appear that the possibility of fetal harm is remote. Nevertheless, meclizine, or any other medication, should be used during pregnancy only if clearly necessary.

ADVERSE REACTIONS

Drowsiness, dry mouth and, on rare occasions, blurred vision have been reported.

DOSAGE AND ADMINISTRATION

Motion Sickness

The initial dose of 25 to 50 mg of meclizine hydrochloride should be taken one hour prior to travel for protection against motion sickness. Thereafter, the dose may be repeated every 24 hours for the duration of the journey.

HOW SUPPLIED

Meclizine Hydrochloride Tablets USP are available as:

12.5 mg, blue, oval-shaped tablets, bisected and debossed with “Є” to the left of bisect and “12” to the right of bisect on one side, and plain on the other side. They are supplied as follows:

NDC 42806-012-01 in bottles of 100

NDC 42806-012-10 in bottles of 1000

25 mg, white, oval-shaped tablets, bisected and debossed with “Є” to the left of bisect and “14” to the right of bisect on one side, and plain on the other side. They are supplied as follows:

NDC 42806-014-01 in bottles of 100

NDC 42806-014-10 in bottles of 1000

Store at 20º to 25ºC (68 to 77ºF) [See USP Controlled Room Temperature]. Dispense contents in a tight, light-resistant container as defined in the USP, with a child-resistant closure, as required.

Manufactured by:

Epic Pharma, LLC

Laurelton, NY 11413

Made in USA

Issued 01/11

MF012ISS 01/11

OE1035

PRINCIPAL DISPLAY PANEL

Meclizine Hydrochloride Tablets uSP, 12.5 mg - 100 count

PRINCIPAL DISPLAY PANEL

Meclizine Hydrochloride Tablets USP, 12.5 mg - 1000 Count

PRINCIPAL DISPLAY PANEL

Meclizine Hydrochloride Tablets USP, 25 mg - 100 Count

PRINCIPAL DISPLAY PANEL

Meclizine Hydrochloride Tablets USP, 25 mg - 1000 count


MECLIZINE HYDROCHLORIDE 
meclizine hydrochloride tablet
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42806-014
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
MECLIZINE HYDROCHLORIDE (MECLIZINE) MECLIZINE HYDROCHLORIDE12.5 mg
Inactive Ingredients
Ingredient NameStrength
LACTOSE MONOHYDRATE 
CELLULOSE, MICROCRYSTALLINE 
CROSCARMELLOSE SODIUM 
MAGNESIUM STEARATE 
FD&C BLUE NO. 1 
Product Characteristics
ColorWHITEScore2 pieces
ShapeOVALSize13mm
FlavorImprint Code E14
Contains    
Packaging
#Item CodePackage DescriptionMultilevel Packaging
1NDC:42806-014-01100 TABLET in 1 BOTTLENone
2NDC:42806-014-101000 TABLET in 1 BOTTLENone

Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA20029407/15/2011

MECLIZINE HYDROCHLORIDE 
meclizine hydrochloride tablet
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42806-012
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
MECLIZINE HYDROCHLORIDE (MECLIZINE) MECLIZINE HYDROCHLORIDE25 mg
Inactive Ingredients
Ingredient NameStrength
CELLULOSE, MICROCRYSTALLINE 
LACTOSE MONOHYDRATE 
CROSCARMELLOSE SODIUM 
MAGNESIUM STEARATE 
Product Characteristics
ColorBLUEScore2 pieces
ShapeOVALSize10mm
FlavorImprint Code E12
Contains    
Packaging
#Item CodePackage DescriptionMultilevel Packaging
1NDC:42806-012-01100 TABLET in 1 BOTTLENone
2NDC:42806-012-101000 TABLET in 1 BOTTLENone

Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA20029407/15/2011

Labeler - Epic Pharma, LLC (827915443)

Revised: 12/2010 Epic Pharma, LLC